Cat. #153563
SVG-A Cell Line
Cat. #: 153563
Unit size: 1x10^6 cells / vial
Availability: 8-10 weeks
Organism: Human
Tissue: Brain
£575.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Walter Atwood
Institute: Brown University
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: SVG-A Cell Line
- Research fields: Neurobiology
- Organism: Human
- Tissue: Brain
- Conditional: Yes
- Description: Human foetal astrocyte cell line. Susceptible to infection by NL4-3, a T-tropic strain of HIV-1. SV40 transformed cell line.
- Biosafety level: 1
- Cellosaurus id: CVCL_5G13
Handling
- Format: Frozen
- Growth medium: DMEM supplemented with 10% FBS
- Unit size: 1x10^6 cells / vial
- Shipping conditions: Dry ice
- Storage conditions: Liquid Nitrogen
- Mycoplasma free: Yes
Related Tools
- Related tools: Msh3-/- SVG-A Cell Line ; SVG-A Msh3 1.7X Cell Line
References
- Schweighardt et al. 2001. J Neurovirol. 7(2):155-62. PMID: 11517388. Gee et al. 2003. Virology. 314(1):101-9. PMID: 14517064. Manley et al. 2007. Virology. 366(2):394-404. PMID: 17555786.
![Anti-CAR Whitlow Linker [1C3C3]](https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-300x322.jpg 300w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-280x300.jpg 280w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-954x1024.jpg 954w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-768x824.jpg 768w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025.jpg 1193w)
![Anti-CAR Whitlow Linker [1B4A1]](https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025-300x396.jpg 300w, https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025-227x300.jpg 227w, https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025-776x1024.jpg 776w, https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025-768x1013.jpg 768w, https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025.jpg 970w)
